Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvianolic acid A sodium for myocardial protection after PCI in acute STEMI
CTR20213269Phase 2Completed
- Sponsor
- Bencao Tianyuan
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) and acute coronary syndrome (ACS) comparing salvianolic acid A sodium with placebo (2 arms). Primary endpoint: Myocardial salvage index after PCI. Started Dec 2021; status: completed.
02
Drugs
salvianolic acid a
03
Conditions
myocardial infarction (MI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on CTR20213269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213269.